Sunday
SESSION 55: NEW DEVELOPMENTS AND CONTROVERSIAL ISSUES RELATED TO CAS AND CEA (5-MINUTE TALKS)
Moderators:Peter A. Schneider, MD / Frank J. Veith, MD  
SESSION 55 SCHEDULE
11:42 AM - 11:47 AM Comparison Of 5 Different Guidelines For Treating Carotid Stenosis: How Can Such Differing Interpretations Be Drawn From The Same Data
  Presenter(s):Kosmas I. Paraskevas, MD / Dimitri P. Mikhailidis, MD / Frank J. Veith, MD  
  View Abstract      
11:48 AM - 11:53 AM CREST Cost Comparisons Between CAS And CEA: Possible Flaws In The CREST Cost Data That Make Its Conclusions Misleading
  Presenter(s):W. Charles Sternbergh III, MD  
11:54 AM - 11:59 AM Impact Of Cranial Nerve Defects (CRI) In CREST At One Year: These CRIs Were Minor And Not Equivalent To Strokes
  Presenter(s):Thomas G. Brott, MD  
12:00 PM - 12:05 PM DEBATE: CEA vs. CAS In Symptomatic Patients: The Heart Should Not Rule The Head When Deciding Treatment Strategies
  Presenter(s):A. Ross Naylor, MD, FRCS  
12:06 PM - 12:11 PM DEBATE: CEA vs. CAS In Symptomatic Patients: The Heart Should Rule The Head When Deciding Treatment Strategies
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
12:12 PM - 12:17 PM Which Carotid Patients Needing Invasive Treatment Do I Currently Send For CEA
  Presenter(s):Klaus D. Mathias, MD  
12:18 PM - 12:23 PM Are CAS vs. CEA Trials Inherently Biased: Critical Appraisal Of Endpoints
  Presenter(s):Timothy M. Sullivan, MD  
12:24 PM - 12:29 PM DEBATE: Many Selected Asymptomatic Carotid Stenosis Patients Benefit From CEA: How Should They Be Picked
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Abstract      
12:30 PM - 12:35 PM DEBATE: Not So: With Asymptomatic Carotid Stenosis Patients Any Benefit Of Invasive Treatment Is Outweighed By The Risks
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP  
  View Abstract      
12:36 PM - 12:41 PM Predictors Of Early Adverse Outcomes After CEA: Are They An Indication For CAS
  Presenter(s):Erik E. Debing, MD, PhD  
  View Abstract      
12:42 PM - 12:47 PM Current Strategies For Treating Carotid And Vertebral Dissections
  Presenter(s):L. Nelson Hopkins, MD  
  View Abstract      
12:48 PM - 12:53 PM Is A Postop MI With Only A Rise In Troponin A Bad Thing And Predictive Of Late Increased Mortality Risk
  Presenter(s):Andres Schanzer, MD  
12:54 PM - 12:59 PM Current Stent Design For CAS Procedures Is Inadequate: What Is On The Horizon To Remedy This
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
1:00 PM - 1:20 PM Panel Discussion
Lunch Available in the Grand Ballroom
END OF SESSION 55
previous next